Workshop on Erythropoietin (EPO-R) Expression and Function in Non-Hematopoietic Tissues, September 8

OVERVIEW:

The Hematology Program of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH) announces a 2-day workshop on Erythropoietin Receptor (EPO-R) Expression and Function in Non-Hematopoietic Tissues, which will be held in Bethesda, Maryland, on September 8 and 9, 2008. This workshop will address evolving insights into the distribution and function of EPO-R in non-hematopoietic tissues. The workshop will summarize clinical observations indicating non-hematopoietic effects of erythropoietin (EPO) in patients with renal failure and solid tumors, and it will review experimental and clinical findings of EPO effects on the development, growth, and function of vascular endothelial cells, tumor cells, and cardiovascular and neural tissues. The workshop will include presentations by both invited speakers and speakers selected from submitted abstracts, together with poster presentations.

This workshop is designed to promote interactions and discussion among workshop participants and to define key unanswered questions and highlight priorities and directions for future research. A limited number of travel grants will be made available to registrants whose abstracts are selected for oral presentations at the workshop. Space at the workshop will be limited, and so early registration is encouraged. Registrants who submit abstracts for presentation at the workshop will be given preference if the number of registrants exceeds available space. REGISTER HERE: http://www.scgcorp.com/eporeceptor2008/registration.asp.

WORKSHOP ORGANIZERS:
*Connie Noguchi*	NIDDK, NIH
*Murat Arcasoy*	Duke University
*Daniel Wright*	NIDDK, NIH

INVITED SPEAKERS:
*H. Frank Bunn*	Brigham and Women’s Hospital, Harvard University
*Connie Noguchi*	NIDDK, NIH
*John Adamson*	University of California at San Diego
*Ajay K. Singh*	Brigham and Women’s Hospital, Harvard University
*Charles L. Bennett*	Northwestern University
*Kenneth Maiese*	Wayne State University
*Max Gassmann*	University Hospital Zurich
*B. Daan Westenbrink*	University Medical Center Groningen
*Walter Koch*	Thomas Jefferson University, Jefferson Medical College
*Jing Chen*	Children's Hospital Boston, Harvard University
*Blanche Alter*	National Cancer Institute, NIH
*ZhiYong Chen*	Walter Reed Army Institute of Research
*Sandra Juul*	University of Washington
*Ahmet Hoke*	Johns Hopkins Medical Institute
*Michael Chopp*	Henry Ford Health Science Center
*Hannelore Ehrenreich*	Max-Planck Institute of Experimental Medicine, University Hospital Münster, Göttingen
*Murat Arcasoy*	Duke University
*Xiaowei Xu*	University of Pennsylvania
*Arthur Sytkowski*	Beth Israel Deaconess Medical Center, Harvard University
*Harvey Lodish*	Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology

TOPICS:

Overviews of EPO and EPO-R Biology
Observations from the Clinical Use of EPO Indicating Non-Hematopoietic Effects
EPO-R Expression and Function in Cardiovascular Tissues
EPO-R Expression and Function in Neural Tissues
EPO-R Expression and Function in Solid Tumor Neoplasias

For Information about Registration and Abstract Submission, Please Contact:

Michelle Watson
Senior Conference Manager
The Scientific Consulting Group, Inc.
656 Quince Orchard Road, Suite 210
Gaithersburg, MD 20878
Phone: (301) 670-4990
Fax: (301) 670-3815
Email: mwatson@scgcorp.com

For Information about the Workshop Program, Please Contact:

Dr. Daniel Wright
NIDDK, NIH
Phone: (301) 594-7714
Email: dw341u@nih.gov